Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues $ 3,800 $ 0
Cost of revenues 900 0
Gross profit 2,900 0
Research and development expense 391 476
Selling, general and administrative expenses 6,710 7,945
Total operating expenses 7,101 8,421
Loss from operations (4,201) (8,421)
Other income (expense)    
Interest and other expense (77) (118)
Interest and other income 130 204
Loss before income taxes (4,148) (8,335)
Provision (benefit) for income taxes 41 (2,333)
Net loss (4,189) (6,002)
Net loss to common stockholder $ (4,189) $ (6,002)
Net loss per share, basic and diluted (in dollars per share) $ (0.15) $ (0.22)
Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) $ (0.15) $ (0.22)
Weighted-average common shares outstanding, basic (in shares) 27,677,579 27,594,372
Weighted-average common shares outstanding, diluted (in shares) 27,677,579 27,594,372